Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Jul
14
Today In Oncology
Breast Cancer: Tailoring Radiotherapy Based on Nodal Response to Primary Chemotherapy
Novel Gene Therapy–Radiotherapy Combination in Localized Prostate Cancer
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
Emergency Hospital Admission Accounts for 40 of Ovarian Cancer Diagnoses in England
Perioperative Systemic Therapy vs Surgery Alone in Colorectal Peritoneal-Only Metastases
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo